Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a first-in-human Phase 1 trial registration with no results posted; it is early-stage safety and pharmacokinetic work designed to establish initial tolerability and drug behavior.
This is a completed registry record for a small interventional study with surrogate endpoints (body composition) in a narrow population, testing dose-response; results are not yet reported, so the evidence strength cannot be assessed.